Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs.
作者信息
Bucolo Claudio, Toro Mario Damiano, Eandi Chiara M
机构信息
Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.
Chair and Department of General and Pediatric Ophthalmology, Medical University of Lublin, Lublin, Poland.
出版信息
Front Pharmacol. 2022 Feb 14;13:848332. doi: 10.3389/fphar.2022.848332. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs.社论：眼部药理学：近期突破与未满足的需求
Front Pharmacol. 2022 Feb 14;13:848332. doi: 10.3389/fphar.2022.848332. eCollection 2022.
2
Protein Microarrays: Valuable Tools for Ocular Diseases Research.蛋白质微阵列：眼部疾病研究的有价值工具。
Curr Med Chem. 2020;27(27):4549-4566. doi: 10.2174/0929867326666190627131300.
3
Relationships between Hearing Loss and the Prevalences of Cataract, Glaucoma, Diabetic Retinopathy, and Age-Related Macular Degeneration in Korea.韩国听力损失与白内障、青光眼、糖尿病视网膜病变及年龄相关性黄斑变性患病率之间的关系。
J Clin Med. 2019 Jul 22;8(7):1078. doi: 10.3390/jcm8071078.
4
Religiousness, Anxiety and Depression in Patients with Glaucoma, Age-Related Macular Degeneration and Diabetic Retinopathy.宗教信仰、焦虑和抑郁与青光眼、年龄相关性黄斑变性和糖尿病性视网膜病变患者。
Psychiatr Danub. 2021 Spring-Summer;33(Suppl 4):965-973.
5
Anti-vascular endothelial growth factor therapy for ocular neovascular disease.抗血管内皮生长因子疗法治疗眼部新生血管疾病。
Curr Opin Ophthalmol. 2007 Nov;18(6):502-8. doi: 10.1097/ICU.0b013e3282f0ca54.
6
Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy.青光眼、年龄相关性黄斑变性和糖尿病性视网膜病变中的循环生物标志物。
Indian J Ophthalmol. 2017 Mar;65(3):191-197. doi: 10.4103/ijo.IJO_866_16.
7
The Eger Macular Stressometer: pilot study.埃格黄斑压力计：初步研究。
Am J Ophthalmol. 2003 Aug;136(2):314-7. doi: 10.1016/s0002-9394(03)00208-3.
8
The Muranga Teleophthalmology Study: A Comparison of Virtual (Teleretina) Assessment with in-person Clinical Examination to Diagnose Diabetic Retinopathy and Age-related Macular Degeneration in Kenya.穆朗加分中心远程眼科研究：肯尼亚虚拟（远程视网膜）评估与现场临床检查诊断糖尿病视网膜病变和年龄相关性黄斑变性的比较
Middle East Afr J Ophthalmol. 2020 Jul 20;27(2):91-99. doi: 10.4103/meajo.MEAJO_144_19. eCollection 2020 Apr-Jun.
9
Inner retinal layer comparisons of eyes with exudative age-related macular degeneration and eyes with age-related macular degeneration and glaucoma.渗出性年龄相关性黄斑变性患者的眼睛与年龄相关性黄斑变性合并青光眼患者的眼睛的视网膜内层比较。
Graefes Arch Clin Exp Ophthalmol. 2014 Apr;252(4):563-70. doi: 10.1007/s00417-013-2496-z. Epub 2013 Oct 22.
10
Diabetic retinopathy and age-related macular degeneration in the U.S.美国的糖尿病视网膜病变和年龄相关性黄斑变性
Am J Prev Med. 2012 Jul;43(1):48-54. doi: 10.1016/j.amepre.2012.02.028.
引用本文的文献
1
Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性的视力预后：一项基于真实世界人群的队列研究。
Pharmaceuticals (Basel). 2023 Jun 26;16(7):927. doi: 10.3390/ph16070927.
本文引用的文献
1
HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.HAWK和HARRIER：布罗鲁单抗治疗新生血管性年龄相关性黄斑变性3期试验的96周结果
Ophthalmology. 2021 Jan;128(1):89-99. doi: 10.1016/j.ophtha.2020.06.028. Epub 2020 Jun 20.
2
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.依普利酮治疗活动期、未经治疗超过 4 个月的慢性中心性浆液性脉络膜视网膜病变（VICI）患者：一项随机、双盲、安慰剂对照试验。
Lancet. 2020 Jan 25;395(10220):294-303. doi: 10.1016/S0140-6736(19)32981-2.
3
Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat.基于小干扰RNA（siRNA）沉默HuR表达的纳米系统可对抗大鼠糖尿病视网膜病变。
Pharmacol Res. 2016 Sep;111:713-720. doi: 10.1016/j.phrs.2016.07.042. Epub 2016 Jul 27.
Zotero 插件